CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy President and CEO bought 15,000 shares at $2.01 ($30,224)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 6,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shareholder vote results
- 4 Open-market buy Director bought 200,000 shares at $2.25 ($450,000)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 6,000 shares (option exercise)
- 4 Option exercise Director acquired 6,000 shares (option exercise)
- 4 Option exercise Director acquired 6,000 shares (option exercise)
Page 8 of 38 · 755 filings